Protalix BioTherapeutics
PLX
#8915
Rank
HK$1.08 B
Marketcap
HK$13.47
Share price
-1.14%
Change (1 day)
6.18%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2025 (TTM): HK$71.39 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are HK$61.94 Million. In 2024 the company made an earning of HK$40.6 Million a decrease over its 2023 earnings that were of HK$91.5 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$71.39 M75.83%
2024 HK$40.6 M-55.62%
2023 HK$91.5 M-199.05%
2022 -HK$92.38 Million-40.38%
2021 -HK$0.16 Billion-732.31%
2020 HK$24.5 M-130.53%
2019 -HK$80.26 Million189.85%
2018 -HK$27.69 Million-95.29%
2017 -HK$0.59 Billion308.12%
2016 -HK$0.15 Billion-32.37%
2015 -HK$0.22 Billion10.11%
2014 -HK$0.2 Billion-7.59%
2013 -HK$0.21 Billion
2011 -HK$0.25 Billion-19.39%
2010 -HK$0.31 Billion20.87%
2009 -HK$0.25 Billion32.26%
2008 -HK$0.19 Billion-5.46%
2007 -HK$0.2 Billion
2004 -HK$1.29 Million12.35%
2003 -HK$1.15 Million-11.1%
2002 -HK$1.3 Million-57.03%
2001 -HK$3.01 Million1.03%
2000 -HK$2.98 Million-53.22%
1999 -HK$6.36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amicus Therapeutics
FOLD
HK$38.78 M-45.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$4.53 B 6,251.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$92.26 B 128,978.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$13.79 B 19,198.63%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel